| Metric | შპს გენომიქსი | შპს სისხლის ბანკი | შპს სენამედ-პლიუსი | სს პრივატი |
|---|---|---|---|---|
| Growth | ||||
| Revenue | ₾1.3m₾1.5m | ₾1.4m₾3.1m | ₾1.2m₾1.0m | ₾1.5m₾1.5m |
| Revenue growth | -13.2% | -55.1% | 18.3% | -4.3% |
| Profitability | ||||
| EBITDA | -₾304k-₾249k | ₾29k | ||
| ₾77k-₾42k |
| ₾374k₾212k |
| EBITDA margin | -22.9%-16.3% | 2.1%15.1% | 6.3%-4.1% | 25.3%13.7% |
| Net profit | -₾277k-₾149k | -₾33k₾317k | ₾77k-₾42k | ₾9.4m₾2.9m |
| Net margin | -20.9%-9.8% | -2.3%10.1% | 6.3%-4.1% | 632.7%186.8% |
| Balance sheet | ||||
| Total assets | ₾2.6m₾2.9m | ₾1.9m₾2.7m | ₾1.8m₾1.6m | ₾47.7m₾41.0m |
| Total equity | ₾1.2m₾1.5m | ₾1.8m₾2.7m | ₾1.5m₾1.4m | ₾26.1m₾17.5m |
| ROE | -23.2%-10.1% | -1.8%11.8% | 5.1%-2.9% | 35.8%16.5% |